AdΔ24 and the p53-expressing variant AdΔ24-p53 achieve potent anti-tumor activity in glioma when combined with radiotherapy-Reference-Cited by-同舟云学术

AdΔ24 and the p53-expressing variant AdΔ24-p53 achieve potent anti-tumor activity in glioma when combined with radiotherapy

Published:2007 Issue:12 Volume:9 Page:1046-1056
ISSN:1099-498X
Container-title:The Journal of Gene Medicine
language:en
Short-container-title:J. Gene Med.

Author:

Idema Sander,Lamfers Martine L.M.,van Beusechem Victor W.,Noske David P.,Heukelom Stan,Moeniralm Sharif,Gerritsen Winald R.,Vandertop W. Peter,Dirven Clemens M.F.

Publisher

Wiley

Subject

Genetics (clinical),Drug Discovery,Genetics,Molecular Biology,Molecular Medicine

Reference42 articles.

1. Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

2. Innate Immune Mechanisms Dominate Elimination of Adenoviral Vectors FollowingIn VivoAdministration

3. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo

4. Brain tumours: classification and genes

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of viruses in cancer development versus cancer therapy: An oncological perspective;Cancer Medicine;2023-03-07

2. Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements;Frontiers in Immunology;2022-08-25

3. Oncolytic virus therapy in cancer: A current review;World Journal of Virology;2021-09-25

4. MDM2/X Inhibitors as Radiosensitizers for Glioblastoma Targeted Therapy;Frontiers in Oncology;2021-07-08

5. RESEARCH PROGRESS ON IMMUNOLOGICAL CHARACTERISTICS AND IMMUNOTHERAPY OF BRAIN GLIOMAS;ACTA MEDICA MEDITERR;2021